Stem cell treatment for hepatitis B–related cirrhosis
Part of Digestive system, Infections clinical trials.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis due to hepatitis B infection
- Your liver disease is in the “decompensated” stage (Child-Pugh B)
- You must be able and willing to participate in the study
- You do not have liver cancer or any other cancer
- You do not have hepatitis C or HIV infections
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment made from stem cells (from umbilical cord fluid) that may help reduce liver scarring and improve liver function in people with cirrhosis. It is an early-stage trial to see if the treatment is safe and feasible.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
This study tests whether stem cells from umbilical cord blood can safely help people with advanced liver scarring (cirrhosis) caused by hepatitis B. It may offer a new option for those who haven't improved with usual treatments.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
This Phase 1 study tests a stem cell product to see if it is safe and how it affects people with worsening hepatitis B-related cirrhosis. It may help researchers understand whether the treatment could improve liver function in this stage of illness.
This trial tests whether a stem cell infusion made from umbilical cord tissue can help people with severe liver failure caused by hepatitis B. The stem cells may reduce liver damage and improve recovery.
Hear when a new Liver Cirrhoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.